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1078–5884/00Invited CommentaryIn this article, Zarins et al. compared the data from the
UK small aneurysm trial (2) with their own published
series (22). In addition, theymatcheda subgroup thatfits
better, but not totally, with the surveillance arm of the
UK trial. Because the length of follow-up differed
between the studies, it was standardised per time
period. The comparison indicates that fatal ruptures
and AAA related deaths after EVAR were statistically
fewer compared to the surveillance. AAA rupture was
not the only cause for death in these cohorts of patients
with multiple vascular and pulmonary risk factors and
therefore the effect on the overall mortality was less
pronounced, but still significant. Additionally, in theUK
surveillance arm after 3 years 62% of the patients had
undergone surgical repair, the majority with an AAAO
5.5 cm,meaning that the survivors had a high likelihood
of requiring surgical repair of their aneurysm. Due to
this fact, manypatientsmight prefer surgery as younger
individuals. The short term advantage of EVAR over
open repair has been documented by the EVAR trial (17)
and is supported by theDREAM trial (18). Furthermore,
the probability of a better success of the EVAR in smaller
aneurysms is supported by the Eurostar data (19). Thus
this article strongly supports the need for trials of EVAR
vs. surveillance in small aneurysms. In Europe the
CAESAR trial has already begun and in the USA the
PIVOTAL study will start soon.
Jan Brunkwall
Cologne, GermanyScientific Trickery
Goodqualitydataandmoney talk (are influential). Level
1 (best quality) evidence from two small aneurysm trials
leaves little suspicion that long-term survival would be
improved by an early intervention to exclude the
aneurysm, however low the procedure-associated 30-
daymortality rate.1,2 Surveillance of small aneurysms is
safe, about one-third of patients die of another cause
before their aneurysm reaches 5.5 cm in diameter.
Almost two-thirds eventually require an intervention
when their aneurysm expands toO5.5 cm in diameter,
but without any increase in 30-day mortality.0504+ 01 $35.00/0 q 2005 Published by Elsevier Ltd.There is no scientific validity in comparing results
in very different populations with very different
lengths of follow-up, without access to all the original
data. Zarins and colleagues should have compared
their subgroup of patients recruited in a USA selected
centre series of AneuRx endografts with patients,
matched for demographic and fitness characteristics,
from the ADAM trial1 and used life table analysis for
unbiased presentation of results. Of course, without
access to original data, life table analysis cannot be
presented. Comparison of their AneuRx trial sub-
group with data extracted from publications of an
earlier randomised trial, representative of British open
repair practice and with twice the length of patient
follow-up,2 might be regarded as scientific trickery.
Recent clinical trials indicate that endovascular
grafting could have an important role for the treatment
of aneurysms R5.5 cm diameter.3,4 The investment of
companies in developing these grafts and their desire
to find a market is appreciated. This market should be
where aneurysm exclusion is necessary to prevent
aneurysm rupture and save life. There is just a
suspicion that Zarins and colleagues are using
inappropriate comparisons in an attempt to find new
markets for endovascular devices.
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